SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009483
Filing Date
2017-05-09
Accepted
2017-05-08 17:43:51
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20170331.htm 10-Q 1688058
2 EX-10.37 ptla-ex1037_355.htm EX-10.37 758114
3 EX-31.1 ptla-ex311_6.htm EX-31.1 9685
4 EX-31.2 ptla-ex312_7.htm EX-31.2 9711
5 EX-32.1 ptla-ex321_8.htm EX-32.1 8762
  Complete submission text file 0001564590-17-009483.txt   6813471

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptla-20170331.xml EX-101.INS 1336190
7 XBRL TAXONOMY EXTENSION SCHEMA ptla-20170331.xsd EX-101.SCH 45908
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20170331_cal.xml EX-101.CAL 38077
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20170331_def.xml EX-101.DEF 163388
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20170331_lab.xml EX-101.LAB 340180
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20170331_pre.xml EX-101.PRE 279122
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 17823685
SIC: 2834 Pharmaceutical Preparations